文献速递心脏核医学

术前首过放射性核素血管造影预测左心室辅助装置植入后右心衰竭的价值评估

Assessing the utility of pre-operative first pass radionuclide angiography to predict right ventricular failure post left ventricular assist device implantation.
PubMed 文献 · J Nucl Cardiol · 2019-09-23

本研究回顾性纳入2008年1月至2017年11月期间接受首过放射性核素血管造影(FPRNA)及左心室辅助装置(LVAD)植入的46例患者,比较发生与未发生右心衰竭(RVF)两组间FPRNA derived的右心室射血分数、右心室扩张及整体功能。8例发生RVF,两组RV EF平均值分别为41.45%与40.13%(P=0.787),RV扩张(P=0.896)及整体RV功能(P=0.827)均无统计学差异。结论认为,在因需进一步评估右心室功能而接受FPRNA的患者中,FPRNA所测RV EF降低、RV扩张及整体RV功能与LVAD植入后RVF风险增加无关。

要点

  • FPRNA测得的RV EF降低与LVAD植入后RVF风险增加无关。
  • FPRNA所见的RV扩张及整体RV功能与RVF风险无统计学关联。
  • 本研究样本量小(46例,8例RVF),结论需谨慎解读。

核心结论

  • 在需要FPRNA进一步评估右心室功能的LVAD术前患者中,FPRNA所测RV EF降低、RV扩张及整体RV功能与LVAD植入后RVF风险增加无关。

研究设计与样本

  • 回顾性研究,纳入2008年1月至2017年11月期间接受FPRNA及LVAD植入的46例患者。
  • RVF定义为LVAD植入后需正性肌力药物超过14天或需右心室辅助装置。
  • 采用Mann-Whitney U检验比较序数与连续变量,Fisher精确检验及Pearson χ2检验比较分类变量。

主要发现

  • 46例中8例在装置植入后发生RVF。
  • 未发生RVF组FPRNA平均RV EF为41.45%,发生RVF组为40.13%(P=0.787)。
  • FPRNA所示RV扩张(P=0.896)与整体RV功能(P=0.827)在两组间无统计学差异。

临床怎么用

  • 对于LVAD术前需进一步评估右心室功能的患者,FPRNA所测RV EF、RV扩张及整体RV功能不宜单独用于预测LVAD植入后RVF风险。

局限性

  • 本研究为单中心回顾性研究,样本量较小(46例),RVF事件数少(8例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Right ventricular failure (RVF) after left ventricular assist device (LVAD) placement is associated with worse outcomes. We hypothesized that decreased right ventricular (RV) ejection fraction (EF) as well as qualitative assessments of RV function and dilation, as assessed by first pass radionuclide angiography (FPRNA), are associated with an increased risk of RVF following LVAD implantation. METHODS: We retrospectively identified 46 patients from 1/2008 to 11/2017 that underwent FPRNA and LVAD implantation. RVF was defined as requiring inotropes for greater than 14 days after LVAD implantation or requiring a right ventricular assist device. FPRNA-derived variables of RV performance and structure were compared between those that did and did not have RVF post implant. Statistical analyses were performed with Mann-Whitney U tests for ordinal and continuous variables. Fisher's exact tests and Pearson's χ2 tests were used for categorical variables. RESULTS: Eight patients developed RVF after device implantation. The average RV EF on FPRNA was 41.45% in those that did not develop RVF and 40.13% in those that did (P = 0.787). RV dilation (P = 0.896) and global RV function (P = 0.827) by FPRNA were not statistically different between the two groups. CONCLUSION: In patients that required FPRNA for further assessment of RV function prior to LVAD implantation, decreased RV EF, RV dilation and global RV function on FPRNA were not associated with an increased risk of RVF.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Patel VN, Tam MC, Palardy M, et al. Assessing the utility of pre-operative first pass radionuclide angiography to predict right ventricular failure post left ventricular assist device implantation. J Nucl Cardiol. 2019. PMID: 31549290. doi:10.1007/s12350-019-01898-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。